Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial

by Vijay M. Patil, Nandini Menon, Abhishek Chatterjee, Raees Tonse, Amit Choudhari, Abhishek Mahajan, Ameya D. Puranik, Sridhar Epari, Monica Jadhav, Shruti Pathak, Zoya Peelay, Rutuja Walavalkar, Hemanth K. Muthuluri, Madala Ravi Krishna, Arun Chandrasekharan, Nikhil Pande, Tejpal Gupta, Shripad Banavali, Rakesh Jalali
Published 2022-07-01